首页> 外文OA文献 >Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects
【2h】

Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects

机译:自体骨移植类固醇:初步临床结果。一种治疗骨不连和节段性骨缺损的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical management of delayed healing or nonunion of long bone fractures and segmental bone defects poses a substantial orthopaedic challenge. Surgical advances and bone tissue engineering are providing new avenues to stimulate bone growth in cases of bone loss and nonunion. The reamer-irrigator-aspirator (RIA) device allows surgeons to aspirate the medullary contents of long bones and use the progenitor-rich “flow-through” fraction in autologous bone grafting. Dexamethasone (DEX) is a synthetic steroid that has been shown to induce osteoblastic differentiation. A series of 13 patients treated with RIA bone grafting enhanced with DEX for nonunion or segmental defect was examined retrospectively to assess the quality of bony union and clinical outcomes. Despite the initial poor prognoses, promising results were achieved using this technique; and given the complexity of these cases the observed success is of great value and warrants controlled study into both standardisation of the procedure and concentration of the grafting material.
机译:延迟愈合或长骨骨折和节段性骨缺损的不愈合的临床处理对骨科提出了严峻的挑战。外科手术的进展和骨组织工程学为骨丢失和骨不连的情况提供了刺激骨生长的新途径。扩孔器-冲洗器-抽吸器(RIA)装置使外科医生可以抽吸长骨的髓质,并在自体骨移植中使用富含祖细胞的“流通”级分。地塞米松(DEX)是一种合成类固醇,已显示可诱导成骨细胞分化。回顾性分析了13例接受DEA增强的RIA植骨治疗的不愈合或节段性缺损的患者,以评估骨结合的质量和临床结局。尽管最初的预后很差,但使用这种技术仍取得了可喜的结果。考虑到这些案例的复杂性,观察到的成功非常有价值,因此有必要对移植方法的标准化和接枝材料的浓度进行对照研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号